Raymond James Financial Services Advisors’s Vera Therapeutics VERA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$800K	Buy	18,101 +85	+0.5%	+$3.23K	﹤0.01%	2308
2024 Q2	$652K	Sell	18,016 -1,064	-6%	-$42.2K	﹤0.01%	2362
2024 Q1	$823K	Buy	19,080 +1,252	+7%	+$44.6K	﹤0.01%	2183
2023 Q4	$274K	Hold	17,828	–	–	﹤0.01%	2800
2023 Q3	$244K	Hold	17,828	–	–	﹤0.01%	2794
2023 Q2	$286K	Hold	17,828	–	–	﹤0.01%	2689
2023 Q1	$138K	Hold	17,828	–	–	﹤0.01%	3008
2022 Q4	$345K	Hold	17,828	–	–	﹤0.01%	2493
2022 Q3	$380K	Hold	17,828	–	–	﹤0.01%	2428
2022 Q2	$243K	Hold	17,828	–	–	﹤0.01%	2746
2022 Q1	$419K	Hold	17,828	–	–	﹤0.01%	2481
2021 Q4	$476K	Hold	17,828	–	–	﹤0.01%	2402
2021 Q3	$309K	Hold	17,828	–	–	﹤0.01%	2674
2021 Q2	$236K	Buy	+17,828	New	+$277K	﹤0.01%	2892

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial Services Advisors's VERA Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Vera Therapeutics (VERA) stake by 0.47% in Q3 2024, buying an estimated $3.23K and bringing the position to 18,101 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Raymond James Financial Services Advisors first reported a position in VERA in Q2 2021 and has held it in 14 quarters since. The position peaked at $823K in Q1 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

Raymond James Financial Services Advisors held 18,101 shares of Vera Therapeutics worth $800K as of Q3 2024.
Raymond James Financial Services Advisors bought 85 Vera Therapeutics shares in Q3 2024, an estimated $3.23K.
Vera Therapeutics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2308 holding.
Raymond James Financial Services Advisors first reported a position in Vera Therapeutics in Q2 2021 and has held it in 14 quarters since.
Raymond James Financial Services Advisors's Vera Therapeutics position peaked at $823K in Q1 2024.
173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.